New York Presbyterian Hospital (Cornell Campus) Interventional Radiology - Integrated

Topics

• Venous Thromboembolism Diagnosis and Management 93
• Hepatocellular Carcinoma Treatment and Prognosis 90
• Diagnosis and Treatment of Venous Diseases 53
• Radiology practices and education 32
• Lung Cancer Diagnosis and Treatment 21
• Gallbladder and Bile Duct Disorders 17
• Renal cell carcinoma treatment 16
• Uterine Myomas and Treatments 13
• Lymphatic Disorders and Treatments 12
• Peripheral Artery Disease Management 11
• Acute Ischemic Stroke Management 10
• Central Venous Catheters and Hemodialysis 10

Most cited

1. 2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/SVN Guideline for the Evaluation and Management of Acute Pulmonary Embolism in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

   Circulation · 2026 · 73 citations · Akhilesh Sista

2. 2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/SVN Guideline for the Evaluation and Management of Acute Pulmonary Embolism in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

   Journal of the American College of Cardiology · 2026 · 52 citations · Akhilesh Sista

3. Indigo Aspiration System for Treatment of Pulmonary Embolism: Results of the EXTRACT-PE Trial.

   JACC. Cardiovascular interventions · 2021 · 290 citations · Akhilesh Sista

4. The Symptoms-Varices-Pathophysiology classification of pelvic venous disorders: A report of the American Vein & Lymphatic Society International Working Group on Pelvic Venous Disorders.

   Journal of vascular surgery. Venous and lymphatic disorders · 2021 · 125 citations · Neil Khilnani

5. Genicular artery embolization for treatment of knee osteoarthritis pain: Systematic review and meta-analysis.

   Osteoarthritis and cartilage open · 2023 · 76 citations · Akhilesh Sista

6. Neoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer: a single-centre, randomised phase 2 trial.